Position history for UBS Group AG's holdings in PROQR THRAPEUTICS N V
UBS Group AG holds 305,264 shares of PRQR (PROQR THRAPEUTICS N V), worth $494,528 as of 2026-Q1. The position was decreased (-61.7% shares). PRQR represents 0.0% of UBS Group AG's portfolio.
Current Value
$494,528
Current Shares
305,264
Total Value Change
+$448,802
Total Shares Change
+277,718
Other major holders of PRQR: ADAGE CAPITAL PARTNERS GP, L.L.C., RTW INVESTMENTS, LP
Decreased |
| 305,264 |
-61.7% |
| $494,528 |
| 0.0% |
| $1.50 |
0 |
| 2025-Q4 | Increased | 797,664 | +743.6% | $1.6M | 0.0% | $2.00 | 41 |
| 2025-Q3 | Decreased | 94,550 | -91.7% | $201,391 | 0.0% | $2.19 | 0 |
| 2025-Q2 | Decreased | 1.1M | -36.0% | $2.3M | 0.0% | $2.04 | 0 |
| 2025-Q1 | Decreased | 1.8M | -22.6% | $2.4M | 0.0% | $1.40 | 0 |
| 2024-Q4 | Increased | 2.3M | +796x | $6.1M | 0.0% | $2.65 | 44 |
| 2024-Q3 | Decreased | 2,900 | -89.5% | $5,278 | 0.0% | $1.83 | 0 |
| 2024-Q2 | Increased | 27,546 | +454.3% | $45,726 | 0.0% | $1.66 | 22 |